Form S-3 Pulmatrix Inc For: 4 June
- Investing.com
- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Pulmatrix Inc (PULM)
Track today's live Pulmatrix (PULM) share price, performance and key data on this page with our current NASDAQ:PULM stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Pulmatrix share price on the NASDAQ exchange. Use the dropdown to switch exchange for the PULM share price, head to our technical summary section, which provides analysis on Pulmatrix share price buy/sell indicators using real-time data (or discuss the Pulmatrix (PULM) stock price today with other investors in the Pulmatrix NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ:PULM share price (ISIN: US74584P3010) to enhance your trading decisions with our free investment tools and resources.
What Is the Pulmatrix Inc Share Price Today?
The Pulmatrix share price today is 1.7300.
What Is the Stock Symbol for Pulmatrix Inc
The stock symbol (or 'ticker') for Pulmatrix Inc is "PULM."
What Stock Exchange Does Pulmatrix Inc Trade On?
Pulmatrix Inc is listed and trades on the NASDAQ stock exchange.
Is Pulmatrix Inc a Good Stock to Buy?
Determining whether Pulmatrix (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current NASDAQ:PULM share price (ISIN: US74584P3010) to enhance your trading decisions with our free investment tools and resources.
What Is the Pulmatrix Inc Share Price Today?
The Pulmatrix share price today is 1.7300.
What Is the Stock Symbol for Pulmatrix Inc
The stock symbol (or 'ticker') for Pulmatrix Inc is "PULM."
What Stock Exchange Does Pulmatrix Inc Trade On?
Pulmatrix Inc is listed and trades on the NASDAQ stock exchange.
Is Pulmatrix Inc a Good Stock to Buy?
Determining whether Pulmatrix (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.6550
1.7400
52 wk Range
1.1600
6.8300
PULM is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.65501.7400
52 wk Range
1.16006.8300
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
PULM Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
RSI suggests the stock is in overbought territory
- Form 10Q Pulmatrix Inc For: 15 May
- Investing.com
- Form 8K Pulmatrix Inc For: 27 March
- Investing.com
- Form 8K Pulmatrix Inc For: 15 May
- Investing.com
- Form S-3 Pulmatrix Inc For: 4 June
- Investing.com
- Form 10Q Pulmatrix Inc For: 15 May
- Investing.com
- Form 8K Pulmatrix Inc For: 15 May
- Investing.com
- Form 8K Pulmatrix Inc For: 21 April
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Earnings
Latest Release
19/05/2026
EPS / Forecast
-0.32 / --
Revenue / Forecast
-- / --
Compare PULM to Peers and Sector
Metrics to compare | PULM | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipPULMPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.4x | −4.5x | −0.4x | |
PEG Ratio | −0.02 | −0.10 | 0.00 | |
Price/Book | 2.4x | 1.4x | 2.6x | |
Price / LTM Sales | - | 17.6x | 3.1x | |
Upside (Analyst Target) | - | 119.8% | 48.3% | |
Fair Value Upside | Unlock | 4.4% | 6.1% | Unlock |
Pulmatrix, Inc., a biopharmaceutical company, focused on development of novel inhaled therapeutic products to prevent and treat migraine and respiratory diseases with unmet medical needs in the United States. The company offers iSPERSE, an engineered dry powder delivery platform, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. It engages in developing PUR1800, a narrow spectrum kinase inhibitor completed Phase 1b clinical trials for the treatment of acute exacerbations in chronic obstructive pulmonary disease; PUR1900 for the treatment of allergic bronchopulmonary aspergillosis in patients with asthma and cystic fibrosis; and PUR3100, an iSPERSE formulation of dihydroergotamine which is in Phase 1 for the treatment of acute migraine. It has a license agreement with RespiVert Ltd. for access to a portfolio of kinase inhibitor compounds. The company was founded in 2003 and is headquartered in Framingham, Massachusetts.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Pulmatrix (NASDAQ: PULM) Share Price Today?
The Pulmatrix stock price today is 1.7300 USD.
What Stock Exchange Does Pulmatrix (PULM) Trade On?
Pulmatrix is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Pulmatrix?
The stock symbol (also called a 'ticker') for Pulmatrix is "PULM."
What Is the Current Pulmatrix Market Capitalisation?
As of today, Pulmatrix (NASDAQ: PULM) market cap is 6.3200M USD.
What Is Pulmatrix's (PULM) Earnings Per Share (TTM)?
The Pulmatrix EPS is currently -1.2392 (Trailing Twelve Months).
When Is the Next Pulmatrix Earnings Date?
Pulmatrix's next earnings report will be released on 12/08/2026.
Is PULM a Buy or Sell From a Technical Analyst Perspective?
Based on today's Pulmatrix moving averages and other technical indicators, the daily buy/sell signal for PULM stock is Strong Buy.
How Many Times Has Pulmatrix Stock Split?
Pulmatrix has split 3 times. (See the PULM stock split history page for full effective split date and price information.)
How Many Employees Does Pulmatrix Have?
Pulmatrix has 2 employees, based on their latest Companies House report.
What is the current trading status of Pulmatrix (NASDAQ: PULM)?
As of 07/07/2026, Pulmatrix (PULM) is trading at a share price of 1.7300 USD, with a previous close of 1.7300 USD. The stock has fluctuated within a day range of 1.6550 USD to 1.7400 USD, while its 52-week range spans from 1.1600 USD to 6.8300 USD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.